Sumitomo Pharma Co., Ltd. (4506.T)
JPY 941.0
(5.26%)
JPY 941.0
(5.26%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 389.83 Billion JPY | 103.85% |
| 2022 | 191.23 Billion JPY | 189.47% |
| 2021 | 66.06 Billion JPY | -17.54% |
| 2020 | 80.12 Billion JPY | -59.18% |
| 2019 | 196.27 Billion JPY | 284.54% |
| 2018 | -106.35 Billion JPY | -5.96% |
| 2017 | -100.37 Billion JPY | -2845.28% |
| 2016 | -3.4 Billion JPY | 12.88% |
| 2015 | -3.91 Billion JPY | -106.99% |
| 2014 | 55.96 Billion JPY | -22.54% |
| 2013 | 72.25 Billion JPY | -24.93% |
| 2012 | 96.24 Billion JPY | -16.34% |
| 2011 | 115.04 Billion JPY | -17.03% |
| 2010 | 138.66 Billion JPY | -8.76% |
| 2009 | 151.97 Billion JPY | 791.12% |
| 2008 | -21.99 Billion JPY | 6.7% |
| 2007 | -23.56 Billion JPY | 52.93% |
| 2006 | -50.06 Billion JPY | 4.76% |
| 2005 | -52.56 Billion JPY | -93.12% |
| 2004 | -27.22 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 311.67 Billion JPY | -20.05% |
| 2024 Q2 | 290.29 Billion JPY | -6.86% |
| 2023 FY | 389.83 Billion JPY | 103.85% |
| 2023 Q2 | 323.4 Billion JPY | 16.62% |
| 2023 Q3 | 375.38 Billion JPY | 16.07% |
| 2023 Q4 | 389.83 Billion JPY | 3.85% |
| 2023 Q1 | 277.31 Billion JPY | 45.01% |
| 2022 Q2 | -837 Million JPY | -106.21% |
| 2022 Q1 | 13.46 Billion JPY | -79.61% |
| 2022 FY | 191.23 Billion JPY | 189.47% |
| 2022 Q4 | 191.23 Billion JPY | 1290.85% |
| 2022 Q3 | -16.05 Billion JPY | -1818.64% |
| 2021 Q3 | 73.41 Billion JPY | -35.58% |
| 2021 Q4 | 66.06 Billion JPY | -10.01% |
| 2021 FY | 66.06 Billion JPY | -17.54% |
| 2021 Q1 | 102.23 Billion JPY | 27.6% |
| 2021 Q2 | 113.95 Billion JPY | 11.47% |
| 2020 Q3 | 74.68 Billion JPY | -54.1% |
| 2020 Q2 | 162.72 Billion JPY | -11.5% |
| 2020 FY | 80.12 Billion JPY | -59.18% |
| 2020 Q1 | 183.86 Billion JPY | -6.32% |
| 2020 Q4 | 80.12 Billion JPY | 7.28% |
| 2019 FY | 196.27 Billion JPY | 284.54% |
| 2019 Q4 | 196.27 Billion JPY | 12.71% |
| 2019 Q3 | 174.14 Billion JPY | 228.79% |
| 2019 Q2 | -135.21 Billion JPY | -13.85% |
| 2019 Q1 | -118.76 Billion JPY | -11.67% |
| 2018 Q1 | -92.28 Billion JPY | 8.06% |
| 2018 Q4 | -106.35 Billion JPY | 1.41% |
| 2018 Q3 | -107.87 Billion JPY | -2.58% |
| 2018 FY | -106.35 Billion JPY | -5.96% |
| 2018 Q2 | -105.16 Billion JPY | -13.96% |
| 2017 Q2 | -32.29 Billion JPY | -28.1% |
| 2017 Q1 | -25.2 Billion JPY | -639.64% |
| 2017 FY | -100.37 Billion JPY | -2845.28% |
| 2017 Q4 | -100.37 Billion JPY | -122.5% |
| 2017 Q3 | -45.11 Billion JPY | -39.71% |
| 2016 Q4 | -3.4 Billion JPY | 28.79% |
| 2016 Q1 | -26 Billion JPY | -564.7% |
| 2016 Q2 | -69.4 Billion JPY | -166.9% |
| 2016 FY | -3.4 Billion JPY | 12.88% |
| 2016 Q3 | -4.78 Billion JPY | 93.1% |
| 2015 Q2 | 39.79 Billion JPY | -35.97% |
| 2015 FY | -3.91 Billion JPY | -106.99% |
| 2015 Q3 | 24.21 Billion JPY | -39.15% |
| 2015 Q4 | -3.91 Billion JPY | -116.16% |
| 2015 Q1 | 62.14 Billion JPY | 11.03% |
| 2014 Q3 | 56.36 Billion JPY | -7.28% |
| 2014 Q2 | 60.78 Billion JPY | -8.54% |
| 2014 Q1 | 66.46 Billion JPY | -8.01% |
| 2014 FY | 55.96 Billion JPY | -22.54% |
| 2014 Q4 | 55.96 Billion JPY | -0.7% |
| 2013 Q1 | 87.86 Billion JPY | -8.71% |
| 2013 Q3 | 80.76 Billion JPY | -2.67% |
| 2013 FY | 72.25 Billion JPY | -24.93% |
| 2013 Q4 | 72.25 Billion JPY | -10.54% |
| 2013 Q2 | 82.98 Billion JPY | -5.55% |
| 2012 FY | 96.24 Billion JPY | -16.34% |
| 2012 Q2 | 102.81 Billion JPY | -2.66% |
| 2012 Q3 | 101.04 Billion JPY | -1.73% |
| 2012 Q1 | 105.62 Billion JPY | -8.19% |
| 2012 Q4 | 96.24 Billion JPY | -4.74% |
| 2011 FY | 115.04 Billion JPY | -17.03% |
| 2011 Q1 | 127.03 Billion JPY | -8.39% |
| 2011 Q3 | 120.76 Billion JPY | -3.18% |
| 2011 Q2 | 124.73 Billion JPY | -1.81% |
| 2011 Q4 | 115.04 Billion JPY | -4.73% |
| 2010 Q3 | 145.84 Billion JPY | -0.25% |
| 2010 Q4 | 138.66 Billion JPY | -4.93% |
| 2010 Q2 | 146.21 Billion JPY | -4.73% |
| 2010 Q1 | 153.48 Billion JPY | 0.99% |
| 2010 FY | 138.66 Billion JPY | -8.76% |
| 2009 Q3 | 190.03 Billion JPY | 984.29% |
| 2009 FY | 151.97 Billion JPY | 791.12% |
| 2009 Q4 | 151.97 Billion JPY | -20.03% |
| 2009 Q2 | -21.49 Billion JPY | 0.0% |
| 2008 Q4 | -21.99 Billion JPY | 0.0% |
| 2008 FY | -21.99 Billion JPY | 6.7% |
| 2007 FY | -23.56 Billion JPY | 52.93% |
| 2006 FY | -50.06 Billion JPY | 4.76% |
| 2005 FY | -52.56 Billion JPY | -93.12% |
| 2004 FY | -27.22 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | -31723.429% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 91.112% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 212.517% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | 11037.825% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 1024.749% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 734.149% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 498.069% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | 58546.327% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 852.276% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | 1284.159% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | -5028.085% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | -4910.114% |
| Tsumura & Co. | 1.61 Billion JPY | -24038.514% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 982.783% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | 1232.03% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | -125.723% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | -1364.232% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | -1245.111% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | -5421.771% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | -55274.574% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | -6405.958% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | 6081.841% |
| MedRx Co., Ltd | -1.72 Billion JPY | 22764.942% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | 4572.421% |
| Solasia Pharma K.K. | -668 Million JPY | 58458.832% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | 26602.631% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | 5474.838% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | -589.708% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | 13266.73% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 496.059% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | 3602.705% |